Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study.

MLA

Pintos-Rodríguez, Samuel, et al. “Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study.” The International Journal of Neuropsychopharmacology, vol. 27, no. 4, Apr. 2024. EBSCOhost, https://doi.org/10.1093/ijnp/pyae020.

APA

Pintos-Rodríguez, S., Visos-Varela, I., Rodríguez-Fernández, A., Zapata-Cachafeiro, M., Piñeiro-Lamas, M., Herdeiro, M. T., García-Álvarez, R. M., Figueiras, A., & Salgado-Barreira, Á. (2024). Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study. The International Journal of Neuropsychopharmacology, 27(4). https://doi.org/10.1093/ijnp/pyae020

Chicago

Pintos-Rodríguez, Samuel, Irene Visos-Varela, Almudena Rodríguez-Fernández, Maruxa Zapata-Cachafeiro, María Piñeiro-Lamas, María Teresa Herdeiro, Rosa María García-Álvarez, Adolfo Figueiras, and Ángel Salgado-Barreira. 2024. “Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study.” The International Journal of Neuropsychopharmacology 27 (4). doi:10.1093/ijnp/pyae020.